Skip to main content
Table of Contents
Print

Are There Risks Associated with Long-Term Cannabis Use for Arthritis? 

Author: Dr. Clarissa Morton, PharmD

As arthritis is a lifelong condition, patients often ask, is it safe to use cannabis long term? 

The answer depends on several factors, including the compound (CBD vs. THC), dosage, delivery method, and a patient’s individual health profile. This article explores what we know about long-term cannabis arthritis use, outlines potential chronic cannabis risks, and highlights important safety considerations for UK patients managing chronic symptoms. 

Understanding Long-Term Cannabis Use in Arthritis Care 

For many people living with arthritis, cannabis-based treatment offers consistent relief from pain, stiffness, and poor sleep. When used correctly, it can significantly improve the quality of life. 

Long-term cannabis arthritis use generally refers to daily or frequent dosing over months or years. This is common in patients with persistent or degenerative joint conditions such as osteoarthritis or inflammatory arthritis. 

While long-term use can support comfort and mobility, it’s not without risks, particularly when THC is used regularly. Patients and prescribers must remain aware of potential downsides and review treatment plans regularly. 

Potential Risks of Regular THC Use 

THC (tetrahydrocannabinol) is the psychoactive compound in cannabis. While it can be effective for chronic arthritis pain, especially in the evenings or during flare-ups, it requires careful dosing over time. 

Cognitive and Psychological Effects 

Long-term exposure to high THC levels may affect: 

  • Short-term memory 
  • Concentration and attention 
  • Mood stability 

Patients with a personal or family history of anxiety, depression, or psychosis should exercise caution. Though these effects are less common under medical supervision, the risk increases with frequent, high-dose use.  

Dependency Risk 

Although addiction to medical cannabis is rare when managed clinically, psychological dependency and tolerance can occur with unsupervised or escalating use. 

This is particularly relevant for patients who increase their dose without guidance or who rely on THC daily without breaks. Chronic cannabis risks are related more to dosage patterns than to the medicine itself. 

Sedation and Impaired Driving 

The sedative effects of THC, particularly when taken in the evening, can last into the next morning and cause drowsiness, reduced reaction times, or difficulty concentrating. 

Driving laws in the UK are very strict. Patients must always follow their prescriber’s instructions and refrain from driving if THC is likely to impair performance. These are examples of real-life arthritis weed side effects that can impact safety and independence. 

Long-Term CBD Use: What We Know 

Even at higher dosages and for longer periods of time, CBD (cannabidiol) is generally well-tolerated and does not cause intoxication like THC does. 

Research and patient experience suggest that CBD and THC long use carries fewer risks when CBD is the dominant compound. However, there are still some points to consider: 

  • Mild side effects include fatigue, diarrhoea, and appetite changes 
  • Liver enzyme interactions can occur, especially for those taking medicines like statins or blood thinners 
  • Long-term human data is still emerging, though early results are promising 

CBD provides a safe, long-lasting solution for chronic pain and inflammation in the majority of arthritis patients, even over several months or years. 

How to Reduce Risk with Medical Supervision 

The best way to manage the chronic cannabis risks of long-term treatment is with continuous clinical supervision. In the UK, prescribing clinics monitor patients regularly and make changes when necessary. 

Key risk-reduction strategies include 

  • Routine dose reviews to prevent tolerance and overuse 
  • Blood tests when needed to check for interactions or liver enzyme changes 
  • Titration plans for THC: Starting low, increasing slowly, and pausing when needed 
  • Using CBD-dominant formulations to limit psychoactive effects 
  • Scheduled “tolerance breaks” to maintain therapeutic benefit 

To ensure that cannabis treatment remains effective, lawful, and clinically appropriate for long-term use, UK clinics prioritise safe, organised care. 

Final Thoughts 

Medical cannabis can offer meaningful, long-term relief for people with arthritis, but it should never be used in a “set and forget” fashion. 

Most of the known risks come from frequent THC use or poorly managed dosing, not from the plant itself. With clinical supervision, clear goals, and regular reviews, these risks can be greatly reduced. 

Whether you’re new to medical cannabis or already using it daily, remember: the key to safe, sustainable relief is ongoing guidance and responsible use

Long-term cannabis arthritis treatment can be a valuable tool, but it works best when part of a thoughtful, well-monitored plan. Learn more about medicinal cannabis treatment plans on our website, LeafEase.

Disclaimer: This article is for information only. Please consult a qualified medical professional before starting or continuing cannabis-based treatment. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories